Growing up in Milan, Italy, Andrea graduated with a Bachelor of Science in Biotechnology (2005) and a Master of Science in Industrial Biotechnology/Pharmacogenomics (2008). In 2009, Andrea moved to Berlin, where he completed his PhD in Cell Biology (2014) at the Humboldt University of Berlin, where he studied the interactions between the HIV-1 structural protein Gag and intracellular calcium-modulated pathways, and developed a nanomedical system based on immunoliposomes, for in vitro clearance of HIV-particles by macrophages. After a short post-doc at the Max Planck Institute of Colloids and Interfaces (Potsdam, Germany), in 2015 Andrea moved to San Francisco, where he joined Dr. Warner Greene’s laboratory, at the Gladstone Institutes/UCSF. In the Greene lab, Andrea’s research focused on finding new ways to reduce the size of the latent HIV-reservoir with a therapeutic approach called “shock and kill.” In October 2019, Andrea joined Dr. Brad Jones’ laboratory. He is currently working on the application of a nanomedical approach to attack HIV infected cells in vivo in a humanized-mice model, and is investigating the role of cellular metabolism in the elimination of HIV-infected CD4+ T cells by cytotoxic T lymphocytes.

Fun fact: I hate fun facts